H.R. 6867 · 119th Congress (2025–2027)
NIH Clinical Trial Integrity Act
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 6867’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Robin L. Kelly (D-IL-2)
- Cosponsors
11 cosponsors
1 original · 10 later
1 R · 10 D
- Rep. Brian K. Fitzpatrick (R-PA-1)· Original · Dec 18, 2025
- Rep. Sean Casten (D-IL-6)· Later · Jan 7, 2026
- Rep. Gwen Moore (D-WI-4)· Later · Jan 7, 2026
- Rep. Jennifer L. McClellan (D-VA-4)· Later · Jan 7, 2026
- Del. Eleanor Holmes Norton (D-DC)· Later · Jan 7, 2026
- Rep. Mark Pocan (D-WI-2)· Later · Jan 7, 2026
- Rep. Melanie A. Stansbury (D-NM-1)· Later · Jan 7, 2026
- Rep. Paul Tonko (D-NY-20)· Later · Jan 7, 2026
- Rep. Josh Gottheimer (D-NJ-5)· Later · Jan 13, 2026
- Rep. Pramila Jayapal (D-WA-7)· Later · Jan 15, 2026
- Rep. Jason Crow (D-CO-6)· Later · Jan 21, 2026
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
NIH Clinical Trial Integrity Act
Display title, Short title · Introduced in House
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes.
Official title · Introduced in House